Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · Soni Medicare Limited · 9 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
Soni Medicare Limited BSE: 539378
Soni Medicare Limited
StateQ4 FY26 filed
Last close—
Market cap—
TTM P/E · P/B · EV/EBITDA— · — · —
Soni Medicare Limited is a listed company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
₹ crore · standalone
FY22
FY23
FY24
FY25
FY26
Revenue
23
28
27
30
25
EBITDA (ex other income)
0
(0)
(2)
(0)
(2)
margin %
0.7
(0.8)
(5.6)
(0.3)
(9.9)
Owners' profit
(1)
(1)
(2)
(0)
(3)
EPS, as reported (₹)
(2.82)
(1.58)
(3.94)
0.70
(5.94)
ROE % · ROCE %
(15.1) · 0.6
(20.4) · 1.0
(104.1) · (6.6)
(13.0) · 6.7
219.5 · (12.9)
Debt / equity (x)
1.70
2.33
6.05
7.98
(10.49)
Cash from operations
(2)
0
0
2
(1)
Capex
(1)
(0)
(0)
(1)
(0)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · Soni Medicare Limited · 9 October 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 8 quarters
₹ crore
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Q2 FY26
Q3 FY26
Q4 FY26
Revenue
7
8
8
7
7
6
5
6
Profit before tax
(1)
0
(0)
0
(0)
(1)
(1)
(0)
Net profit
(1)
0
(0)
0
(0)
(1)
(1)
(0)
EPS (₹)
(2.03)
1.09
(0.31)
0.55
(0.68)
(2.16)
(2.65)
0.45
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · Soni Medicare Limited · 9 October 2026Page 3 of 3
Exhibit 3: Filings of the last 90 days, with the measured price reaction
Date · filing
Category
Importance
1-day %
5-day %
7 Sept 2026 · Notice of 38th AGM and Annual Report FY 2025-26 for shareholders
compliance
minimal
—
—
7 Sept 2026 · Soni Medicare Annual Report FY26 - Revenue Down, Net Loss
board shareholder meetings
medium
—
—
7 Sept 2026 · Notice of 38th AGM scheduled for 29 September 2026
board shareholder meetings
low
—
—
7 Sept 2026 · Intimation of 38th AGM, Book Closure and E-voting Details
board shareholder meetings
low
—
—
7 Sept 2026 · AGM intimation: 38th AGM on 29 Sep 2026, book closure from 23 Sep 2026
board shareholder meetings
low
—
—
17 Aug 2026 · Soni Medicare publishes Q1 FY26-27 standalone results in newspapers
compliance
minimal
—
—
23 Jul 2026 · Board approves PNB bank guarantee, authorizes MD for RGHS work
credit debt
low
—
—
15 Jul 2026 · RTA Certificate Under SEBI Regulation 74(5) for Q1 FY27
compliance
minimal
—
—
29 Jun 2026 · Trading window closed from July 1 ahead of Q1 FY27 results
compliance
minimal
—
—
Source: exchange announcements; reaction = close-to-close from the filing's session.
How to read this document
Where a broker report shows
This document shows
Why
A rating (BUY / ADD / REDUCE / SELL)
A state: the latest filed quarter and the measured reactions
an event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upside
The current price and the multiples against the group
a target is a forecast; a multiple is a measurement
Estimate years marked E
More audited years; no estimates
MarketPing publishes no forecasts — your own model lives on the Models page
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
